世界のヘパリン市場2023~2027:低分子ヘパリン、その他

■ 英語タイトル:Global Heparin Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR40831-22)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR40831-22
■ 発行日:2022年11月3日
■ 調査対象地域:ヨーロッパ、北米、アジア、その他地域
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のヘパリン市場2023~2027:低分子ヘパリン、その他]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

テクナビオ社の本調査レポートでは、世界のヘパリン市場規模が2023年から2027年の間に3009.44百万ドル成長すると見込んでおり、予測期間中の年平均成長率は6.94%になると予想しています。本レポートでは、ヘパリンの世界市場について広く調査を行い、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別分析(低分子ヘパリン、その他)、投与経路別分析(皮下注射、静脈注射/点滴)、顧客状況、地域別分析(北米、アジア、その他地域、アメリカ、イギリス、ドイツ、中国、フランス)、企業分析などを以下の構成でまとめております。本レポートには、Aspen Pharmacare Holdings、B. Braun SE、Baxter International Inc.、Dr Reddys Laboratories Ltd.、Eisai Co. Ltd.、Fresenius SE and Co. KGaA、Hebei Changshan Biochemical、Hikma Pharmaceuticals Plc、Laboratorios Farmaceuticos Roviなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のヘパリン市場規模:製品別
- 低分子ヘパリンの市場規模
- その他の市場規模
・世界の暖房付き寝具市場規模:投与経路別
- 皮下注射における市場規模
- 静脈注射/点滴における市場規模
・顧客状況
・地域別状況
- 北米のヘパリン市場規模
- アジアのヘパリン市場規模
- その他地域のヘパリン市場規模
- アメリカのヘパリン市場規模
- イギリスのヘパリン市場規模
- ドイツのヘパリン市場規模
- 中国のヘパリン市場規模
- フランスのヘパリン市場規模
・成長要因・課題・動向
・企業状況
・企業分析

テクナビオ社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 テクナビオ社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

Global Heparin Market 2023-2027
Technavio has been monitoring the heparin market and is poised to grow by $3009.44 mn from 2023-2027, accelerating at a CAGR of 6.94% during the forecast period. Our report on the heparin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of coagulation disorders, the increasing prevalence of chronic conditions, and the reintroduction of alternative sources to produce heparin.

Technavio’s heparin market is segmented as below:

By Product
• Low-molecular-weight heparin
• Others

By Route of Administration
• Subcutaneous injection
• Intravenous/infusion

By Geographical Landscape
• Europe
• North America
• Asia
• Rest of World (ROW)

This study identifies the increasing R&D activities and new therapeutic applications of heparin as one of the prime reasons driving the heparin market growth during the next few years. Also, the advent of biosimilar low-molecular-weight heparin and the development of drugs to remove heparin after surgery will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the heparin market covers the following areas:
• Heparin market sizing
• Heparin market forecast
• Heparin market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heparin market vendors that include Aspen Pharmacare Holdings, B. Braun SE, Baxter International Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hebei Changshan Biochemical, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos Rovi, LEO Pharma AS, Nanjing Kingfriend Biochemical, Nichi Iko Pharmaceutical Co. Ltd., Novartis AG, Opocrin SpA, Pfizer Inc., Sanofi SA, Shanghai Fosun Pharmaceutical Group Co. Ltd., Shenzhen Techdow Pharmaceutical, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the heparin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics

• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

• 4 Historic Market Size
o 4.1 Global heparin market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global heparin market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Route of administration Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Low-molecular-weight heparin – Market size and forecast 2022-2027
o Exhibit 34: Chart on Low-molecular-weight heparin – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Low-molecular-weight heparin – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Low-molecular-weight heparin – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Low-molecular-weight heparin – Year-over-year growth 2022-2027 (%)
o 6.4 Others – Market size and forecast 2022-2027
o Exhibit 38: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)

• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 43: Chart on Route of Administration – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Route of Administration – Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 45: Chart on Comparison by Route of Administration
o Exhibit 46: Data Table on Comparison by Route of Administration
o 7.3 Subcutaneous injection – Market size and forecast 2022-2027
o Exhibit 47: Chart on Subcutaneous injection – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Subcutaneous injection – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Subcutaneous injection – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Subcutaneous injection – Year-over-year growth 2022-2027 (%)
o 7.4 Intravenous/infusion – Market size and forecast 2022-2027
o Exhibit 51: Chart on Intravenous/infusion – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Intravenous/infusion – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Intravenous/infusion – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Intravenous/infusion – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 55: Market opportunity by Route of Administration ($ million)

• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 Europe – Market size and forecast 2022-2027
o Exhibit 61: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.4 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 81: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 93: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)

• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends

• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business

• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Aspen Pharmacare Holdings
o Exhibit 104: Aspen Pharmacare Holdings – Overview
o Exhibit 105: Aspen Pharmacare Holdings – Business segments
o Exhibit 106: Aspen Pharmacare Holdings – Key offerings
o Exhibit 107: Aspen Pharmacare Holdings – Segment focus
o 12.4 B. Braun SE
o Exhibit 108: B. Braun SE – Overview
o Exhibit 109: B. Braun SE – Business segments
o Exhibit 110: B. Braun SE – Key news
o Exhibit 111: B. Braun SE – Key offerings
o Exhibit 112: B. Braun SE – Segment focus
o 12.5 Baxter International Inc.
o Exhibit 113: Baxter International Inc. – Overview
o Exhibit 114: Baxter International Inc. – Business segments
o Exhibit 115: Baxter International Inc. – Key news
o Exhibit 116: Baxter International Inc. – Key offerings
o Exhibit 117: Baxter International Inc. – Segment focus
o 12.6 Eisai Co. Ltd.
o Exhibit 118: Eisai Co. Ltd. – Overview
o Exhibit 119: Eisai Co. Ltd. – Business segments
o Exhibit 120: Eisai Co. Ltd. – Key offerings
o Exhibit 121: Eisai Co. Ltd. – Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 122: Fresenius SE and Co. KGaA – Overview
o Exhibit 123: Fresenius SE and Co. KGaA – Business segments
o Exhibit 124: Fresenius SE and Co. KGaA – Key news
o Exhibit 125: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 126: Fresenius SE and Co. KGaA – Segment focus
o 12.8 Hikma Pharmaceuticals Plc
o Exhibit 127: Hikma Pharmaceuticals Plc – Overview
o Exhibit 128: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 129: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 130: Hikma Pharmaceuticals Plc – Segment focus
o 12.9 Laboratorios Farmaceuticos Rovi
o Exhibit 131: Laboratorios Farmaceuticos Rovi – Overview
o Exhibit 132: Laboratorios Farmaceuticos Rovi – Business segments
o Exhibit 133: Laboratorios Farmaceuticos Rovi – Key offerings
o Exhibit 134: Laboratorios Farmaceuticos Rovi – Segment focus
o 12.10 Nanjing Kingfriend Biochemical
o Exhibit 135: Nanjing Kingfriend Biochemical – Overview
o Exhibit 136: Nanjing Kingfriend Biochemical – Product / Service
o Exhibit 137: Nanjing Kingfriend Biochemical – Key offerings
o 12.11 Nichi Iko Pharmaceutical Co. Ltd.
o Exhibit 138: Nichi Iko Pharmaceutical Co. Ltd. – Overview
o Exhibit 139: Nichi Iko Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 140: Nichi Iko Pharmaceutical Co. Ltd. – Key offerings
o 12.12 Novartis AG
o Exhibit 141: Novartis AG – Overview
o Exhibit 142: Novartis AG – Business segments
o Exhibit 143: Novartis AG – Key offerings
o Exhibit 144: Novartis AG – Segment focus
o 12.13 Pfizer Inc.
o Exhibit 145: Pfizer Inc. – Overview
o Exhibit 146: Pfizer Inc. – Product / Service
o Exhibit 147: Pfizer Inc. – Key news
o Exhibit 148: Pfizer Inc. – Key offerings
o 12.14 Sanofi SA
o Exhibit 149: Sanofi SA – Overview
o Exhibit 150: Sanofi SA – Business segments
o Exhibit 151: Sanofi SA – Key news
o Exhibit 152: Sanofi SA – Key offerings
o Exhibit 153: Sanofi SA – Segment focus
o 12.15 Shenzhen Techdow Pharmaceutical
o Exhibit 154: Shenzhen Techdow Pharmaceutical – Overview
o Exhibit 155: Shenzhen Techdow Pharmaceutical – Product / Service
o Exhibit 156: Shenzhen Techdow Pharmaceutical – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 157: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 158: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 162: Viatris Inc. – Overview
o Exhibit 163: Viatris Inc. – Business segments
o Exhibit 164: Viatris Inc. – Key offerings
o Exhibit 165: Viatris Inc. – Segment focus

• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global heparin market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Route of administration Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Low-molecular-weight heparin – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Low-molecular-weight heparin – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Low-molecular-weight heparin – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Low-molecular-weight heparin – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on Route of Administration – Market share 2022-2027 (%)
Exhibits44: Data Table on Route of Administration – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Subcutaneous injection – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Subcutaneous injection – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Subcutaneous injection – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Subcutaneous injection – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Intravenous/infusion – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Intravenous/infusion – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Intravenous/infusion – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Intravenous/infusion – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Route of Administration ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Aspen Pharmacare Holdings – Overview
Exhibits105: Aspen Pharmacare Holdings – Business segments
Exhibits106: Aspen Pharmacare Holdings – Key offerings
Exhibits107: Aspen Pharmacare Holdings – Segment focus
Exhibits108: B. Braun SE – Overview
Exhibits109: B. Braun SE – Business segments
Exhibits110: B. Braun SE – Key news
Exhibits111: B. Braun SE – Key offerings
Exhibits112: B. Braun SE – Segment focus
Exhibits113: Baxter International Inc. – Overview
Exhibits114: Baxter International Inc. – Business segments
Exhibits115: Baxter International Inc. – Key news
Exhibits116: Baxter International Inc. – Key offerings
Exhibits117: Baxter International Inc. – Segment focus
Exhibits118: Eisai Co. Ltd. – Overview
Exhibits119: Eisai Co. Ltd. – Business segments
Exhibits120: Eisai Co. Ltd. – Key offerings
Exhibits121: Eisai Co. Ltd. – Segment focus
Exhibits122: Fresenius SE and Co. KGaA – Overview
Exhibits123: Fresenius SE and Co. KGaA – Business segments
Exhibits124: Fresenius SE and Co. KGaA – Key news
Exhibits125: Fresenius SE and Co. KGaA – Key offerings
Exhibits126: Fresenius SE and Co. KGaA – Segment focus
Exhibits127: Hikma Pharmaceuticals Plc – Overview
Exhibits128: Hikma Pharmaceuticals Plc – Business segments
Exhibits129: Hikma Pharmaceuticals Plc – Key offerings
Exhibits130: Hikma Pharmaceuticals Plc – Segment focus
Exhibits131: Laboratorios Farmaceuticos Rovi – Overview
Exhibits132: Laboratorios Farmaceuticos Rovi – Business segments
Exhibits133: Laboratorios Farmaceuticos Rovi – Key offerings
Exhibits134: Laboratorios Farmaceuticos Rovi – Segment focus
Exhibits135: Nanjing Kingfriend Biochemical – Overview
Exhibits136: Nanjing Kingfriend Biochemical – Product / Service
Exhibits137: Nanjing Kingfriend Biochemical – Key offerings
Exhibits138: Nichi Iko Pharmaceutical Co. Ltd. – Overview
Exhibits139: Nichi Iko Pharmaceutical Co. Ltd. – Product / Service
Exhibits140: Nichi Iko Pharmaceutical Co. Ltd. – Key offerings
Exhibits141: Novartis AG – Overview
Exhibits142: Novartis AG – Business segments
Exhibits143: Novartis AG – Key offerings
Exhibits144: Novartis AG – Segment focus
Exhibits145: Pfizer Inc. – Overview
Exhibits146: Pfizer Inc. – Product / Service
Exhibits147: Pfizer Inc. – Key news
Exhibits148: Pfizer Inc. – Key offerings
Exhibits149: Sanofi SA – Overview
Exhibits150: Sanofi SA – Business segments
Exhibits151: Sanofi SA – Key news
Exhibits152: Sanofi SA – Key offerings
Exhibits153: Sanofi SA – Segment focus
Exhibits154: Shenzhen Techdow Pharmaceutical – Overview
Exhibits155: Shenzhen Techdow Pharmaceutical – Product / Service
Exhibits156: Shenzhen Techdow Pharmaceutical – Key offerings
Exhibits157: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits158: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits159: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits160: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits162: Viatris Inc. – Overview
Exhibits163: Viatris Inc. – Business segments
Exhibits164: Viatris Inc. – Key offerings
Exhibits165: Viatris Inc. – Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR40831-22 )"世界のヘパリン市場2023~2027:低分子ヘパリン、その他" (英文:Global Heparin Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。